Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-30

Clinical Trial Update: Role of Thymus-And Activation-Regulated Chemokine (TARC) In Diagnosis Of Allergic Bronchopulmonary Aspergillosis

View source ↗

Summary

An update on a clinical study evaluating thymus and activation-regulated chemokine (TARC) as a diagnostic biomarker for allergic bronchopulmonary aspergillosis.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assiut University | Conditions: Thymus and Activation Regulated Chemokine | Status: UNKNOWN